Advertisement
Organisation › Details
Cellnovo (Group)
An international commercial medical technology company, Cellnovo markets the first mobile, connected all-in-one diabetes management system, a disruptive technology enhancing daily disease management for Type 1 diabetes patients. Cellnovo’s device currently addresses the $2.2 billion insulin pump market and the Company is reviewing the potential for the device to serve other markets. Cellnovo is currently marketing the device in the UK, France and The Netherlands and has a clearly defined commercial and manufacturing strategy supported by strategic partners Air Liquide and Flextronics. Cellnovo is headquartered in Paris, France, with product development facilities in Wales, UK. *
Start | 2016-02-22 existent | |
Industry | healthcare technology | |
Person | Baratte, Sophie (Cellnovo 201602 CEO) | |
Person 2 | Moulin, Thierry (Cellnovo 201602–201703 CFO GING 3/17 before Cellectis + Vergnet + Ermewa + Toshiba TEC) | |
Region | Paris | |
Country | France | |
City | n. a. Paris | |
Address record changed: 2020-12-02 | ||
Basic data | Employees | n. a. |
Currency | EUR | |
Annual sales | 1,058,000 (sales (2017) 2017-12-31) | |
Cash | 13,000,000 (2017-12-31) | |
* Document for »About Section«: | ||
Record changed: 2024-02-12 |
Advertisement
More documents for Cellnovo (Group)
- [1] Cellnovo. (3/28/19). "Press Release: Cellnovo Stops Manufacturing and Commercial Operations. Administrators Appointed at UK Subsidiary Have Actioned a Restructuring Plan to Focus on Identifying Strategic Partners and Investors". Paris....
- [2] Cellnovo. (1/17/18). "Press Release: Cellnovo Announces Its Q4 and Full Year 2017 Sales". Paris....
- [3] Cellnovo. (7/7/17). "Press Release: Cellnovo Successfully Raises €17.5 Million from Healthcare Investors [Not for Distribution in the United States of America, Canada, Australia and Japan]"....
- [4] Cellnovo. (7/6/17). "Press Release: Cellnovo Launches a Capital Increase for Approximately €15 Million [Not for Distribution in the United States of America, Canada, Australia and Japan]"....
- [5] Reuters. (7/6/17). "News: BRIEF – Cellnovo Launches Capital Increase for approx. 15 Million Euros"....
- [6] Cellnovo. (4/3/17). "Press Release: Cellnovo Appoints Erwan Martin as Chief Financial Officer". Paris....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Advertisement
» top